CDK 4/6 inhibitors: Management of side effects
15 Nov 2016
CDK 4/6 inhibitors: Management of side effects
Closing poll on CDK inhibition in advanced breast cancer with failing antiestrogens
TAT 2017 congress provides the latest in Phase I targeted therapies
Advances in malignant melanoma
Can a blood test detect cancer?
Why attend the EurocanPlatform Summer School on translational research?
What involvement do stem cells have in disease and resistance?
How does the protein kinase Akt enable tumours to grow?
Using adoptive cell therapy to fight cancer
European consortium can help accelerate progress in cancer research
What does palbociclib do and what side effects might we see?
Overcoming painful bone disease in myeloma